Zymeworks Inc. (ZYME) Financial Statements (2024 and earlier)

Company Profile

Business Address 108 PATRIOT DRIVE, SUITE A
MIDDLETOWN, DE 19709
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments492,232
Cash and cash equivalents400,912
Short-term investments91,320
Receivables33,400
Other undisclosed current assets19,074
Total current assets:544,706
Noncurrent Assets
Operating lease, right-of-use asset22,937
Property, plant and equipment24,713
Long-term investments and receivables886
Long-term investments886
Intangible assets, net (including goodwill)38,399
Goodwill12,016
Intangible assets, net (excluding goodwill)26,383
Prepaid expense15,729
Deferred income tax assets1,345
Other undisclosed noncurrent assets10
Total noncurrent assets:104,019
TOTAL ASSETS:648,725
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:87,468
Accounts payable7,863
Accrued liabilities31,449
Other undisclosed accounts payable and accrued liabilities48,156
Deferred revenue2,353
Debt16
Other undisclosed current liabilities5,788
Total current liabilities:95,625
Noncurrent Liabilities
Liabilities, other than long-term debt, including:3,101
Accounts payable and accrued liabilities682
Business combination, contingent consideration, liability1,248
Other undisclosed liabilities, other than long-term debt1,171
Other undisclosed noncurrent liabilities57,043
Total noncurrent liabilities:60,144
Total liabilities:155,769
Equity
Equity, attributable to parent, including:492,956
Common stock886,322
Additional paid in capital151,614
Accumulated other comprehensive loss(6,659)
Accumulated deficit(558,763)
Other undisclosed equity, attributable to parent20,442
Total equity:492,956
TOTAL LIABILITIES AND EQUITY:648,725

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
Revenues412,482
Gross profit:412,482
Operating expenses(281,954)
Operating income (loss):130,528
Nonoperating income (expense)1,110
Gain (loss), foreign currency transaction, before tax1,152
Other nonoperating income (expense)(42)
Income (loss) from continuing operations before equity method investments, income taxes:131,638
Other undisclosed income from continuing operations before income taxes3,596
Income (loss) from continuing operations before income taxes:135,234
Income tax expense (benefit)(10,893)
Net income (loss) available to common stockholders, basic:124,341
Other undisclosed net loss available to common stockholders, diluted (231)
Net income (loss) available to common stockholders, diluted:124,110

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
Net income (loss):124,341
Comprehensive income (loss):124,341
Other undisclosed comprehensive income, net of tax, attributable to parent 
Comprehensive income (loss), net of tax, attributable to parent:124,341

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: